Regulation of α-synuclein expression by poly (ADP Ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene

American Journal of Human Genetics

Volumn 76, Issue 3, 2005, Pages 478-492

  Chiba Falek, Ornit ^a   Kowalak, Jeffrey A ^b   Smulson, Mark E ^c   Nussbaum, Robert L ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOBENZAMIDE; ALPHA SYNUCLEIN; BINDING PROTEIN; DNA BINDING PROTEIN; LUCIFERASE; MESSENGER RNA; POLYADENOSINE DIPHOSPHATE RIBOSE POLYMERASE 1; PROTEIN REP1; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENHANCER REGION; ENZYME ACTIVE SITE; ENZYME MECHANISM; FAMILIAL DISEASE; GEL MOBILITY SHIFT ASSAY; GENE; GENE DUPLICATION; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MICROSATELLITE MARKER; PARKINSON DISEASE; POLYMORPHIC LOCUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; SNCA GENE; TRANSCRIPTION REGULATION;

EID: 13844289143     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/428655     Document Type: Article

References (49)

1. Anderson MG, Scoggin KE, Simbulan-Rosenthal CM, Steadman JA (2000) Identification of poly(ADP-ribose) polymerase as a transcriptional coactivator of the human T-cell leukemia virus type 1 Tax protein. J Virol 74:2169-2177
2. Butler AJ, Ordahl CP (1999) Poly(ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription. Mol Cell Biol 19:296-306
3. Cervellera MN, Sala A (2000) Poly(ADP-ribose) polymerase is a B-MYB coactivator. J Biol Chem 275:10692-10696
4. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destee A (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364:1167-1169
5. Chiba-Falek O, Nussbaum RL (2001) Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum Mol Genet 10:3101-3109
6. Chiba-Falek O, Touchman JW, Nussbaum RL (2003) Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene. Hum Genet 113:426-431
7. D'Amours D, Desnoyers S, D'Silva I, Poirier GG (1999) Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 342:249-268
8. Dignam JD, Lebovitz RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489
9. Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D, Langston JW (2004) Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55:174-179
10. Farrer M, Maraganore DM, Lockhart P, Singleton A, Lesnick TG, de Andrade M, West A, de Silva R, Hardy J, Hernandez D (2001) α-Synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet 10:1847-1851
11. Feany MB, Bender WW (2000) A Drosophila model of Parkinson's disease. Nature 404:394-398
12. Golbe LI (1999) Alpha-synuclein and Parkinson's disease. Mov Disord 14:6-9
13. Guermah M, Malik S, Roeder RG (1998) Involvement of TFIID and USA components in transcriptional activation of the human immunodeficiency virus promoter by NF-κB and Sp1. Mol Cell Biol 18:3234-3244
14. Hashimoto M, Hsu LJ, Sisk A, Xia Y, Takeda A, Sundsmo M, Masliah E (1998) Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease. Brain Res 799:301-306
15. Hassa PO, Hottiger MO (2002) The functional role of poly(ADP-ribose) polymerase 1 as novel coactivator of NF-κB in inflammatory disorders. Cell Mol Life Sci 59:1534-1553
16. Ibanez P, Bonnet AM, Debarges B, Lohmann E, Tison F, Pollak P, Agid Y, Durr A, Brice A (2004) Causal relation between α-synuclein gene duplication and familial Parkinson's disease. Lancet 364:1169-1171
17. Izumi Y, Morino H, Oda M, Maruyama H, Udaka F, Kameyama M, Nakamura S, Kawakami H (2001) Genetic studies in Parkinson's disease with an α-synuclein/NACP gene polymorphism in Japan. Neurosci Lett 300:125-127
18. Johnson J, Hague SM, Hanson M, Gibson A, Wilson KE, Evans EW, Singleton AA, McInerney-Leo A, Nussbaum RL, Hernandez DG, Gallardo M, McKeith IG, Burn DJ, Ryu M, Hellstrom O, Ravina B, Eerola J, Perry RH, Jaros E, Tienari P, Weiser R, Gwinn-Hardy K, Morris CM, Hardy J, Singleton AB (2004) SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology 63:554-556
19. Kannan P, Yu Y, Wankhade S, Tainsky MA (1999) PolyADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation. Nucleic Acids Res 27:866-874
20. Khan N, Graham E, Dixon P, Morris C, Mander A, Clayton D, Vaughan J, Quinn N, Lees A, Daniel S, Wood N, de Silva R (2001) Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype. Ann Neurol 49:665-668
21. Kraus WL, Lis JT (2003) PARP goes transcription. Cell 113:677-683
22. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 18:106-108
23. Kruger R, Vieira-Saecker AM, Kuhn W, Berg D, Muller T, Kuhnl N, Fuchs GA, Storch A, Hungs M, Woitalla D, Przuntek H, Epplen JT, Schols L, Riess O (1999) Increased susceptibility to sporadic Parkinson's disease by a certain combined α-synuclein/apolipoprotein E genotype. Ann Neurol 45:611-617
24. Li M, Naidu P, Yu Y, Berger NA, Kannan P (2004) Dual regulation of AP-2α transcriptional activation by poly(ADP-ribose) polymerase-1. Biochem J 382:323-329
25. Maries E, Dass B, Collier TJ, Kordower JH, Steece-Collier K (2003) The role of α-synuclein in Parkinson's disease: insights from animal models. Nat Rev Neurosci 4:727-738
26. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L (2000) Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287:1265-1269
27. Miller DW, Hague SM, Clarimon J, Baptista M, Gwinn-Hardy K, Cookson MR, Singleton AB (2004) α-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 62:1835-1838
28. Miyamoto T, Kakizawa T, Hashizume K (1999) Inhibition of nuclear receptor signalling by poly(ADP-ribose) polymerase. Mol Cell Biol 19:2644-2649
29. Mizuta I, Nishimura M, Mizuta E, Yamasaki S, Ohta M, Kuno S (2002) Meta-analysis of α synuclein/NACP polymorphism in Parkinson's disease in Japan. J Neurol Neurosurg Psychiatry 73:350
30. Nie J, Sakamoto S, Song D, Qu Z, Ota K, Taniguchi T (1998) Interaction of Oct-1 and automodification domain of poly(ADP-ribose) synthetase. FEBS Lett 424:27-32
31. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet JC, de Murcia G (1999) Resistance to endotoxic shock as a consequence of defective NF-κB activation in poly (ADP-ribose) polymerase-1 deficient mice. Embo J 18:4446-4454
32. Ostrerova N, Petrucelli L, Farrer M, Mehta N, Choi P, Hardy J, Wolozin B (1999) α-Synuclein shares physical and functional homology with 14-3-3 proteins. J Neurosci 19:5782-5791
33. Parsian A, Racette B, Zhang ZH, Chakraverty S, Rundle M, Goate A, Perlmutter JS (1998) Mutation, sequence analysis, and association studies of α-synuclein in Parkinson's disease. Neurology 51:1757-1759
34. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047
35. Simbulan-Rosenthal CM, Ly DH, Rosenthal DS, Konopka G, Luo R, Wang ZQ, Schultz PG, Smulson ME (2000) Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 97:11274-11279
36. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) α-Synuclein locus triplication causes Parkinson's disease. Science 302:841
37. Smulson ME, Pang D, Jung M, Dimtchev A, Chasovskikh S, Spoonde A, Simbulan-Rosenthal C, Rosenthal D, Yakovlev A, Dritschilo A (1998) Irreversible binding of poly(ADP)ribose polymerase cleavage product to DNA ends revealed by atomic force microscopy: possible role in apoptosis. Cancer Res 58:3495-3498
38. Soldatenkov VA, Chasovskikh S, Potaman VN, Trofimova I, Smulson ME, Dritschilo A (2002) Transcriptional repression by binding of poly(ADP-ribose) polymerase to promoter sequences. J Biol Chem 277:665-670
39. Spadafora P, Annesi G, Pasqua AA, Serra P, Ciro Candiano IC, Carrideo S, Tarantino P, Civitelli D, De Marco EV, Nicoletti G, Annesi F, Quattrone A (2003) NACP-REP1 polymorphism is not involved in Parkinson's disease: a case-control study in a population sample from southern Italy. Neurosci Lett 351:75-78
40. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) α-synuclein in Lewy bodies. Nature 388:839-840
41. Stone KL, Williams KR (1993) Enzymatic digestion of proteins and HPLC peptide isolation. Academic Press, San Diego, CA
42. Tan EK, Chai A, Teo YY, Zhao Y, Tan C, Shen H, Chandran VR, Teoh ML, Yih Y, Pavanni R, Wong MC, Puvan K, Lo YL, Yap E (2004) Alpha-synuclein haplotypes implicated in risk of Parkinson's disease. Neurology 62:128-131
43. Tan EK, Matsuura T, Nagamitsu S, Khajavi M, Jankovic J, Ashizawa T (2000) Polymorphism of NACP-Rep1 in Parkinson's disease: an etiologic link with essential tremor? Neurology 54:1195-1198
44. Tan EK, Tan C, Shen H, Chai A, Lum SY, Teoh ML, Yih Y, Wong MC, Zhao Y (2003) Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability. Neurosci Lett 336:70-72
45. Touchman JW, Dehejia A, Chiba-Falek O, Cabin DE, Schwartz JR, Orrison BM, Polymeropoulos MH, Nussbaum RL (2001) Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element. Genome Res 11:78-86
46. Virag L, Szabo C (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54:375-429
47. Whitacre CM, Hashimoto H, Tsai ML, Chatterjee S, Berger SJ, Berger NA (1995) Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences. Cancer Res 55:3697-3701
48. Xia Y, Rohan de Silva HA, Rosi BL, Yamaoka LH, Rimmler JB, Pericak-Vance MA, Roses AD, Chen X, Masliah E, DeTeresa R, Iwai A, Sundsmo M, Thomas RG, Hofstetter CR, Gregory E, Hansen LA, Katzman R, Thal LJ, Saitoh T (1996) Genetic studies in Alzheimer's disease with an NACP α-synuclein polymorphism. Ann Neurol 40:207-215
49. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG (2004) The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164-173